Trade Summary

4 days ago, Haas Jason, serving as Dir at LIGAND PHARMACEUTICALS INC (LGND), sold 6,461 shares at $255.58 per share, for a total transaction value of $1,651,320.20. Following this transaction, Haas Jason now holds 4,981 shares of LGND.

This sale represents a 56.47% decrease in Haas Jason's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 (accepted Jun 15, 9:06 PM ET), 4 days after the trade was made.

LIGAND PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.